Excellence in tobacco control research
University of Crete
07 Jul 2015
Dr. Constantine Vardavas is a Research Associate of the Clinic of Social and Family Medicine (CSFM) at the University of Crete, on the Faculty of Medicine of the University of Crete and also at the Hellenic Cancer Society in Athens, Greece.
Dr. Vardavas focuses on the development, implementation and assessment of tobacco control policy initiatives. His works spans national, European, and international tobacco regulatory science and public policy. He has presented his research and provided policy consultation to research institutes, academic institutions, the European Commission and the European Parliament.
In 2014, he moved from Harvard University back to Greece to take a lead role in the projects related to the implementation of the European Tobacco Products Directive and now directly consults the European Commission on the implementation of policies related to multiple issues that include the reporting of tobacco product ingredients to the general public, the regulation and impact of additives within tobacco products and the impact of e-cigarettes on public health.
For his work, Dr. Vardavas recently received the European Cancer League’s “Best Young Professional Award for outstanding research and contribution to tobacco control policy at a European level,” at the 11th ECTOH in Istanbul, and the European Network for Smoking and Tobacco Prevention, “Best Researcher Award for 2015” for excellence in tobacco control research.
Dr. Vardavas is also actively engaged in research on the acute and chronic health effects of tobacco use, e-cigarettes and exposure to secondhand smoke. He is a co-Editor-in-Chief of the journal, Tobacco Induced Diseases, the official journal of the International Society for the Prevention of Tobacco Induced Diseases.
During his time at the Harvard School of Public Health, as a Senior Research Scientist within the Center for Global Tobacco Control, he was the scientific director of the HEART (Hellenic Action for Research Against Tobacco) Project, a Harvard University-led $1.8 million initiative to promote tobacco control and protect public health from the effects of tobacco use and exposure to secondhand smoke in Greece.
Dr. Vardavas is part of a collaborative partnership working to develop a primary care tobacco dependence treatment network in Crete, Greece, a project funded by Pfizer IGLC through Global Bridges. The TiTAN (Tobacco Treatment TrAining Network) Crete project will train primary health care (PHC) providers who will integrate treatment of tobacco dependence into daily clinical practice and become champions of tobacco control policy. He is also the co-PI with Cornel Radu on the European Network for Smoking and Tobacco Prevention’s (ENSP) project EPACTT-EuroPean Accreditation Curriculum on Tobacco Treatment, which is also funded by Pfizer IGLC through Global Bridges.